Kisho

Dicerna Pharmaceuticals, Inc. (a wholly owned subsidiary of Novo Nordisk) — Rare Disease Pipeline | Kisho | Kisho

Dicerna Pharmaceuticals, Inc. (a wholly owned subsidiary of Novo Nordisk)

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
Pelizaeus-Merzbacher disease in female carriers	Rivfloza	Orphan Designation	-
monosomy X	Rivfloza	Orphan Designation	-
mosaic monosomy X	Rivfloza	Orphan Designation	-
primary hyperoxaluria	Rivfloza	Orphan Designation	-